Tag: Endotronix
HFSA 2024: One-year data from PROACTIVE-HF show reduction in heart failure hospitalisation and all-cause mortality
Endotronix has announced the one-year clinical results from PROACTIVE-HF, evaluating outcomes fo...
Edwards Lifesciences continues acquisition spree, announcing JenaValve and Endotronix deals
Edwards Lifesciences has announced further expansion of its structural heart portfolio, after enteri...
Endotronix submits premarket approval application to US FDA for Cordella pulmonary artery sensor
Endotronix has submitted a premarket approval (PMA) application for its Cordella pulmonary arter...
Cordella meets safety and efficacy endpoints in SIRONA 2 clinical trial
Endotronix has announced data from the SIRONA 2 clinical trial evaluating safety and efficacy of...
COVID-19: Optimising heart failure management in the patient’s home
Physicians recognised the importance of remote management for heart failure patients long before...
First patients enrolled in PROACTIVE-HF trial of Cordella pulmonary artery pressure sensor system
Endotronix has announced the enrollment of the first two patients in the PROACTIVE-HF trial. The...
AHA 2019: Endotronix shares data from in-human trial of Cordella pulmonary artery pressure sensor
Endotronix has presented first-in-human data of the Cordella pulmonary artery pressure sensor Sy...
Endotronix closes expanded series D financing round of US$70 million for Cordella
Endotronix has announced the expansion of its series D financing round, bringing the total to US...
Endotronix joins AHA’s Center for Health Technology & Innovation to broaden the use of guideline-based care for heart failure patients
Endotronix has announced they have joined the American Heart Association’s Center for Health Technol...
First-in-human implantation of the Cordella pulmonary artery pressure sensor performed
Endotronix has announced successful first-in-human implantation of the Cordella pulmonary artery...
